These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 25976957

  • 1. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC.
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [Abstract] [Full Text] [Related]

  • 2. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC, McLaren CE, Speechley M, McLaren GD, Barton JC, Eckfeldt JH.
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [Abstract] [Full Text] [Related]

  • 3. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 4. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE, Hutzler S, Bollheimer LC, Buettner R, Hellerbrand C, Schöelmerich J, Palitzsch KD.
    Isr Med Assoc J; 2004 Jan 28; 6(1):30-3. PubMed ID: 14740507
    [Abstract] [Full Text] [Related]

  • 5. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW, Sholinsky P, Reboussin DM, McLaren GD, Harris EL, Bent TC, Vogt TM, Castro O.
    Diabetes Care; 2006 Sep 28; 29(9):2084-9. PubMed ID: 16936157
    [Abstract] [Full Text] [Related]

  • 6. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    Genet Test; 2007 Sep 28; 11(3):269-75. PubMed ID: 17949288
    [Abstract] [Full Text] [Related]

  • 7. Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study.
    Harrison HF, Harrison BW, Walker AP, Lohman K, Ellis SD, Hall MA, Reiss J, Adams PC, Holup J, Acton RT, Bent T, Rivers C, Fadojutimi-Akinsiku M.
    Genet Test; 2008 Dec 28; 12(4):491-500. PubMed ID: 18939938
    [Abstract] [Full Text] [Related]

  • 8. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC, Pankow JS, Barton JC, Acton RT, Leiendecker-Foster C, McLaren GD, Speechley M, Eckfeldt JH.
    Circ Cardiovasc Genet; 2009 Feb 28; 2(1):34-7. PubMed ID: 20031565
    [Abstract] [Full Text] [Related]

  • 9. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL, Filho R, Cruz S, Franco R, Tavella M, Secaf M, Ramalho L, Zucoloto S, Rodrigues S, Zago M.
    Genet Mol Res; 2005 Mar 31; 4(1):31-8. PubMed ID: 15841433
    [Abstract] [Full Text] [Related]

  • 10. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD, Gordeuk VR.
    Hematology Am Soc Hematol Educ Program; 2009 Mar 31; ():195-206. PubMed ID: 20008199
    [Abstract] [Full Text] [Related]

  • 11. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM.
    N Engl J Med; 2008 Jan 17; 358(3):221-30. PubMed ID: 18199861
    [Abstract] [Full Text] [Related]

  • 12. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
    Lim A, Speechley M, Adams PC.
    Can J Gastroenterol Hepatol; 2014 Oct 17; 28(9):502-4. PubMed ID: 25314357
    [Abstract] [Full Text] [Related]

  • 13. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K, Romanowski T, Stalke P, Iżycka-Świeszewska E, Bielawski KP.
    Hepatobiliary Pancreat Dis Int; 2011 Jun 17; 10(3):270-5. PubMed ID: 21669570
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
    Adams PC, Reboussin DM, Leiendecker-Foster C, Moses GC, McLaren GD, McLaren CE, Dawkins FW, Kasvosve I, Acton RT, Barton JC, Zaccaro D, Harris EL, Press R, Chang H, Eckfeldt JH.
    Clin Chem; 2005 Jun 17; 51(6):1048-52. PubMed ID: 15833784
    [No Abstract] [Full Text] [Related]

  • 15. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, Camaschella C.
    Haematologica; 2004 Oct 17; 89(10):1161-7. PubMed ID: 15477198
    [Abstract] [Full Text] [Related]

  • 16. [Hereditary and acquired iron overload].
    de Korwin JD.
    Nephrol Ther; 2006 Nov 17; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [Abstract] [Full Text] [Related]

  • 17. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.
    Vnitr Lek; 2006 Jun 17; 52(6):602-8. PubMed ID: 16871764
    [Abstract] [Full Text] [Related]

  • 18. [Diagnosis of 5 patients with possible primary hemochromatosis].
    Jacobs EM, de Vries RA, Elving LD, Stalenhoef AF, Swinkels DW.
    Ned Tijdschr Geneeskd; 2003 Apr 05; 147(14):666-70. PubMed ID: 12712652
    [Abstract] [Full Text] [Related]

  • 19. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S.
    Scand J Clin Lab Invest; 2006 Apr 05; 66(2):83-100. PubMed ID: 16537242
    [No Abstract] [Full Text] [Related]

  • 20. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
    Aguilar-Martinez P, Grandchamp B, Cunat S, Cadet E, Blanc F, Nourrit M, Lassoued K, Schved JF, Rochette J.
    Haematologica; 2011 Apr 05; 96(4):507-14. PubMed ID: 21228038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.